FOXD3 Regulates VISTA Expression in Melanoma

Immune checkpoint inhibitors have improved patient survival in melanoma, but the innate resistance of many patients necessitates the investigation of alternative immune targets. Many immune checkpoint proteins lack proper characterization, including V-domain Ig suppressor of T cell activation (VISTA...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenbaum, Sheera R., Knecht, Meghan, Mollaee, Mehri, Zhong, Zhijiu, Erkes, Dan A., McCue, Peter A., Chervoneva, Inna, Berger, Adam C., Lo, Jennifer A., Fisher, David E., Gershenwald, Jeffrey E., Davies, Michael A., Purwin, Timothy J., Aplin, Andrew E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995351/
https://www.ncbi.nlm.nih.gov/pubmed/31940493
http://dx.doi.org/10.1016/j.celrep.2019.12.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995351/
https://www.ncbi.nlm.nih.gov/pubmed/31940493
http://dx.doi.org/10.1016/j.celrep.2019.12.036

Ejemplares similares